Akoya Biosciences (AKYA) Earnings Date, Estimates & Call Transcripts → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free AKYA Stock Alerts $4.12 -0.14 (-3.29%) (As of 05/13/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryLatest Earnings DateMar. 4ConfirmedActual EPS (Mar. 4) -$0.22 Beat By $0.05 Consensus EPS (Mar. 4) -$0.27 Read Call TranscriptListen to Call Get Akoya Biosciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for AKYA and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAKYA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AKYA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceHow to Make 100X on the AI BoomFor over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs Akoya Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ2 20241($0.26)($0.26)($0.26) Q3 20241($0.20)($0.20)($0.20) AKYA Earnings Date and InformationAkoya Biosciences last announced its quarterly earnings results on March 4th, 2024. The reported ($0.22) earnings per share for the quarter, beating analysts' consensus estimates of ($0.27) by $0.05. The firm earned $26.49 million during the quarter, compared to analyst estimates of $26.12 million. Akoya Biosciences has generated ($1.48) earnings per share over the last year (($1.48) diluted earnings per share). Earnings for Akoya Biosciences are expected to grow in the coming year, from ($0.86) to ($0.50) per share. Read More Akoya Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript3/4/2024Q4 2023($0.27)($0.22)+$0.05($0.22)$26.12 million$26.49 million 11/8/2023Q3 2023($0.37)($0.26)+$0.11($0.26)$24.53 million$25.22 million8/7/2023Q2 2023($0.44)($0.51)($0.07)($0.51)$22.17 million$23.52 million5/8/2023Q1 2023($0.46)($0.49)($0.03)($0.49)$20.37 million$21.41 million3/6/2023Q4 2022($0.41)($0.50)($0.09)($0.50)$20.85 million$21.22 million 11/7/2022Q3 2022($0.40)($0.47)($0.07)($0.47)$17.80 million$18.85 million Get the Latest News and Ratings for AKYA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akoya Biosciences and its competitors with MarketBeat's FREE daily newsletter. 8/8/2022Q2 2022($0.34)($0.47)($0.13)($0.47)$16.93 million$17.89 million 5/5/2022Q1 2022($0.37)($0.44)($0.07)($0.44)$14.79 million$16.89 million 3/14/2022Q4 2021($0.31)($0.47)($0.16)($0.47)-$16.16 million 11/7/2021Q3 2021($0.26)($0.31)($0.05)($0.31)$12.93 million$13.48 million 8/9/2021Q2 2021($0.23)($0.20)+$0.03($0.20)$12.46 million$13.07 million 5/18/2021Q1 2021($0.15)($2.85)($2.70)($2.16)$12.06 million$12.21 million Akoya Biosciences Earnings - Frequently Asked Questions When did Akoya Biosciences announce their last quarterly earnings? Akoya Biosciences (NASDAQ:AKYA) last announced its quarterly earning data on Monday, March 4, 2024. Learn more on AKYA's earnings history. Did Akoya Biosciences beat their earnings estimates last quarter? In the previous quarter, Akoya Biosciences (NASDAQ:AKYA) reported ($0.22) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.27) by $0.05. Learn more on analysts' earnings estimate vs. AKYA's actual earnings. How can I listen to Akoya Biosciences's earnings conference call? The conference call for Akoya Biosciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Akoya Biosciences's conference call transcript? The conference call transcript for Akoya Biosciences's latest earnings report can be read online. Read Transcript How much revenue does Akoya Biosciences generate each year? Akoya Biosciences (NASDAQ:AKYA) has a recorded annual revenue of $96.63 million. How much profit does Akoya Biosciences generate each year? Akoya Biosciences (NASDAQ:AKYA) has a recorded net income of -$63.32 million. AKYA has generated -$1.48 earnings per share over the last four quarters. What is Akoya Biosciences's EPS forecast for next year? Akoya Biosciences's earnings are expected to grow from ($0.86) per share to ($0.50) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Prelude Therapeutics Earnings Results Seer Earnings Results Sutro Biopharma Earnings Results Athira Pharma Earnings Results Bionano Genomics Earnings Results Nautilus Biotechnology Earnings Results Pacific Biosciences of California Earnings Results Arbutus Biopharma Earnings Results EyePoint Pharmaceuticals Earnings Results Quanterix Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:AKYA) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersGuard Against the Coming Financial UpheavalPorter & CompanyElon’s New Device is About to Shock the WorldInvestorPlaceConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe only AI company you should be looking atBehind the MarketsCharles Payne Demystifies OptionsUnstoppable ProsperityForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akoya Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.